Care Homes in M33

About care in M33

M33 covers Sale town centre and the surrounding neighbourhoods in Trafford, Greater Manchester — a prosperous outer south Manchester suburb with an exceptionally strong care home quality record. The 20 CQC-registered homes here provide 482 beds; two hold Outstanding status — Cheshire House and Lime Tree House — and 15 are rated Good, with just two Requires Improvement and zero Inadequate providers. Trafford Council administers adult social care for M33 residents; as a metropolitan borough council, Trafford has above-average resources for commissioning and assessment compared with rural authorities, and assessment waiting times are generally shorter than the Greater Manchester average. Wythenshawe Hospital (Manchester University NHS Foundation Trust) is a key acute trust for south Manchester discharge pathways, with Trafford General Hospital also serving the area. Four homes offer nursing care, including Amberley Care Home (72 beds) and Ashlands Manor Care Home — the nursing provision is more limited relative to the total bed count, but the residential care market here is extensive. Both Outstanding homes reflect sustained excellence in management and care: Cheshire House and Lime Tree House are regularly referenced by local commissioning teams as benchmark providers for the Trafford area. M33 benefits from excellent transport connections — Sale Metrolink station gives direct tram access to Manchester city centre and Wythenshawe — making it particularly practical for families visiting from across Greater Manchester. Private-pay fees in Sale typically run mid-range for Greater Manchester, above the borough average for East Manchester but below central Salford or premium Cheshire postcodes. The area's strong community infrastructure, including good GP coverage and local pharmacies, supports care homes in managing residents' complex health needs without over-reliance on acute services. Families considering M33 should visit both Outstanding homes first and use their standards as a benchmark when assessing the Good-rated alternatives.